alexa Mass Spectrometry and Florescence Analysis of Snap-Nappa Arrays Expressed Using E. coli Cell_Free Expression System | OMICS International
ISSN: 2157-7439
Journal of Nanomedicine & Nanotechnology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Mass Spectrometry and Florescence Analysis of Snap-Nappa Arrays Expressed Using E. coli Cell_Free Expression System

Claudio Nicolini1,2,3*, Rosanna Spera1,2, Fernanda Festa3, Luca Belmonte1,2, Shaorong Chong4, Eugenia Pechkova1,2 and Joshua Labaer3

1Laboratories of Biophysics and Nanobiotechnology, Department Experimental Medicine, University of Genova, Italy

2Nanoworld Institute Fondazione EL.B.A. Nicolini, Largo Piero Redaelli 7, Pradalunga (Bg), Italy

3Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA

4New England Biolabs, Inc, 240 County Road, Ipswich, UK

*Corresponding Author:
Claudio Nicolini
Professor
President Nanoworld Institute
Fondazione ELBA Nicolini, Italy
E-mail: [email protected]

Received Date: August 20, 2013; Accepted Date: August 30, 2013; Published Date: October 02, 2013

Citation: Nicolini C, et al. (2013) Mass Spectrometry and Florescence Analysis of Snap-Nappa Arrays Expressed Using E. coli Cell_Free Expression System. J Nanomed Nanotechnol 4:181. doi:10.4172/2157-7439.1000181

Copyright: © 2013 Nicolini C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Nanomedicine & Nanotechnology

Keywords

Mass spectrometry; Label-free analysis; Nucleic acid programmable protein array; SNAP tag; E. coli cell-free expression system; PURE express system

Introduction

One of the main challenges in the field of proteomics is to study large number of proteins, identifying their interactions and function. In order to study the complexity of proteome, various proteomic techniques, including protein microarrays, have emerged during the past few years. A protein microarray provides a multiplex platform for high throughput (HT) studies [1,2].

Protein microarrays detection is essentially based on two main strategies, label-based and label-free methods. The label-based technique requires labelling of query molecules with labels such as fluorescent dyes, radioisotopes, epitope tags, etc. [3]; the labeled molecule is then detected via a fluorescence microscope, flow cytometer or some other fluorescence reading instrument [4]. On the contrary label-free analysis do not require the use of reporter elements (fluorescent, luminescent, radiometric, or colorimetric) to facilitate measurements, it can provide direct information on analyte binding to array molecules typically in the form of mass addition or depletion from the array surface [5-7].

Label-based technique presents limitations particularly in the context of measuring naturally occurring ligands, such as in clinical studies where it is not possible to produce fusion proteins: namely the need to obtain a capture antibody for each analyzed protein, and the concern that a labeling molecule may alter the properties of the query protein. A label-free method for the analysis of a microarray would then represent a major advancement [5].

Many label-free techniques such as SPR, quartz crystal microbalance (QCM), carbon nanotubes (CNTs) and nanowires, nanohole arrays, atomic force microscopy (AFM), etc., have been successfully integrated with protein microarrays and are emerging rapidly as a potential complement to labeling methods [7,8]. Among all these techniques, that usually cannot reveal the identity of interaction proteins, MS is powerful to provide chemical and structural information that is difficult to obtain through other means.

Combining MS and other surface techniques could offer new dimensions in protein analysis [5,8]. The integration of microarrays with MS has generated a powerful new tool to deal with the problems in protein analysis and identification area. The most successful example is the ProteinChip® System of Ciphergen Biosystems Inc. The design of the ProteinChip® array was originally derived from chromatography and is divided into two groups according to its surface characteristics; the array reader is a SELDI-TOF-MS instrument equipped with a pulsed UV nitrogen laser source [8].

Also Nedelkov et al. [9] coupled BIACORE with MS to demonstrate its feasibility in detecting multiple protein-protein interactions.In our research we employed two different mass spectrometry (MS) techniques, the Matrix Assisted Laser Desorption Ionization Time-of- Flight (MALDI-TOF) MS and Liquid Chromatography-Electrospray Ionization MS (LC-ESI-MS) (Figure 1).

nanomedicine-nanotechnology-fluorescence-analysis

Figure 1: Fluorescence analysis of SNAP-NAPPA a) Proteins were synthesized by two different IVTT systems, 1-Step Human Coupled IVT (HCIVT) and E. coli IVTT. Slide images were obtained with Power Scanner and the signal intensity was quantified using the Array-ProAnalyzer 6.3. The median intensity across the quadruplicates was measured and the background was corrected through the subtraction of the median value of the negative control with a matching SNAP concentration. b) Proteins yield for different SNAP concentrations, for HCIVT and E. coli IVTT systems. c) The master mix box (spotted with all the reagents of the regular NAPPA spotting mix, except DNA) was the negative control and reference box.

In a previous research we carried out a feasibility study of MALDI TOF MS analysis of Nucleic Acid Programmable Protein Array (NAPPA) [5]. The NAPPA method allows for functional proteins to be synthesized in situ directly from printed cDNAs just in time for assay [10,11]. The use of purified proteins was substituted with the use of cDNAs encoding the target proteins for the microarray.

The design of NAPPA has been directed to overcome the limitations of traditional protein microarray technologies, including minimal manipulation of the proteins and protein repertoire – since cDNA is used as a template for the protein expression the availability of comprehensive cDNA libraries makes it possible to use virtually any cDNA sequence on the array. Moreover the protein stability is preserved since proteins are produced just in time for the assay; once the array is activated for analysis, all reactions occur in solution and in real time so stability is not an issue [2,7,11]. On the base of the results obtained [5] many improvements have been done both to NAPPA technology and expression process and to bioinformatic analysis of the data.

Here we present the results obtained analyzing an improved version of NAPPA [10]; in this improved version the proteins were synthesized with the addition of a SNAP tag – therefore hereafter we name SNAP_ NAPPA this kind of array [12,13] and translated using a reconstituted Escherichia coli coupled cell-free expression system. The addition of a SNAP tag to each protein enabled its capture to the array through an anti-SNAP antibody printed simultaneously with the expression plasmid [14].

SNAP tag is a 20 kDa mutant of the DNA repair protein O6- alkylguanine-DNA alkyltransferase that reacts specifically and rapidly with benzylguanine (BG) derivatives, leading to irreversible covalent labeling of the SNAP tag [12,13,15]. SNAP tag has a number of features that make it ideal for a variety of applications in protein labeling; in particular its substrates are chemically inert towards other proteins, avoiding nonspecific labeling in cellular applications [15]. Moreover also the chemistry and the printing of the NAPPA have been improved.

The last goal of our research is to develop a standardized analysis procedure, able to analyze the protein-protein interactions occurred on NAPPA array in a label free manner. To this aim we employed a MALDITOF mass spectrometer for NAPPA analysis. MALDI technique, in fact, allows to analyze protein samples co-crystallized with the matrix on a conductive surface; for this reason NAPPA were produced on a standard microscope glass covered with a thin layer of gold.

After the NAPPA expression, the proteins immobilized on the array surface were trypsin digested and immediately after analyzed by MALDI-TOF MS, without needing to be removed from the array surface. On the base of the previous results [5], however, we decided, in the present research, to add a further investigation technique, coupling mass spectrometry (electrospray ionization, ESI) with liquid chromatography (LC-MS) to analyze SNAP-NAPPA. LC-ESI MS, because of the connection between the liquid chromatography and mass spectrometer, requires removing the trypsin digested solution from the array surface at the end of the digestion.

Anyhow we decided to employ both MALDI-TOF and LC-ESI MS since, as for our previous research one of the main challenges in evaluating the mass spectra obtained from SNAP-NAPPA was the biological material present on the SNAP-NAPPA together with the target proteins, such as the BSA protein. A chromatographic step, before MS analysis, could reduce the complexity of the sample thus providing better results.

Several improvements have been done also to reduce the sample complexity (i.e. the amount of biological material due to NAPPA chemistry and to the expression system); in particular the in vitro translation-transcription (IVTT) system we used was from E. coli and no more from rabbit reticulocyte lysate (RRL). In the previous experiments, in fact, the proteins were synthesized with a C-terminal glutathione S-transferase (GST) tag (MW 26 kDa) and translated using a T7-coupled RRL IVTT system [5].

The protein translation reaction, one of the most important regulators of cell behavior, involves the interactions of a large number of components, and has been studied extensively because of its importance in the cell [16]. Two approaches have guided efforts to achieve cell-free translation. One approach, developed over the past decade, is based on crude cell extract, often derived from Escherichia coli, rabbit reticulocites, or wheat germ [17]. The second approach attempts to reconstitute protein synthesis from purified components of the translation machinery. More than 100 molecules participate in prokaryotic and eukaryotic translation, many of which have been individually purified for biochemical studies of their functions and structures [18].

Shimizu and coworkers firstly developed a protein-synthesizing system reconstituted from recombinant tagged protein factors purified to homogeneity. The system was able to produce protein at a rate of about 160 μg/ml/h in a batch mode without the need for any supplementary apparatus. Moreover, omission of a release factor allowed efficient incorporation of an unnatural amino acid using suppressor transfer RNA (tRNA). The system was termed the “protein synthesis using recombinant elements” (PURE) system [18,19].

The reconstruction of an E. coli-based in vitro translation system using protein components, highly purified on an individual basis, showed that 36 enzymes and ribosomes are sufficient to carry out protein translation [18]. These minimal protein components include the ribosomal proteins; initiation, elongation, and release factors; aminoacyltRNA synthetases; and enzymes involved in energy regeneration. In addition, many studies have characterized the properties of such individual proteins in detail, for example, by kinetic analysis and three dimensional structural determination, and to quantify the interactions among the components constituting the system [16].

The drawback of any extract-based systems is that they often contain nonspecific nucleases and proteases that adversely affect protein synthesis. In addition, the cell extract is like a “black box” in which numerous uncharacterized activities may modify or interfere with the downstream assays [20]. Except for the ribosomes and tRNAs, which are highly purified from E. coli, the PURE system reconstitutes the E. coli translation machinery with fully recombinant proteins. These include 10 translation factors (IF1, IF2, IF3, EF-Tu, EF-Ts, EF-G, RF1, RF2, RF3, RRF), 20 aminoacyl-tRNA synthetases and several enzymes for energy regeneration (Table 1). In addition, recombinant T7 RNA polymerase is used to couple transcription to translation.

Recombinant proteins
Protein name Gene symbol Protein name Gene symbol
IF1 infA GlnRS glnS
IF2 infB TrpRS trpS
IF3 infC TyrRS tyrS
Methionyl-tRNA formyltransferase Fmt HisRS hisS
EF-Tu TufA ProRS proS
EF-Ts Tsf ThrRS thrS
EF-G fusA SerRS serS
RF1 prfA LysRS lysS
RF2 prfB AsnRS asnS
RF3 prfC AspS aspS1
RRF Frr AlaRS alaS
ArgRS argS GlyRS glyS
CysRS cysS PheRS □2□2 pheS pheT
IleRS ileS Creatine kinase  
LeuRS leuS Nucleotide diphosphate. Kinase Ndk
MetRS metG Myokinase  
ValRS valS Inorganic pyrophosphatase Ppa
GluRS gltX T7 RNA polymerase  
Ribosomal proteins
Protein name Protein name Protein name Protein name
30S ribosomal subunit protein S1 50S ribosomal subunit protein L17 50S ribosomal subunit protein L5 30S ribosomal subunit protein S17
30S ribosomal subunit protein S2 50S ribosomal subunit protein L18 50S ribosomal subunit protein L6 30S ribosomal subunit protein S18
30S ribosomal subunit protein S3 50S ribosomal subunit protein L19 50S ribosomal subunit protein L7/L12 30S ribosomal subunit protein S19
30S ribosomal subunit protein S4 50S ribosomal subunit protein L20 50S ribosomal subunit protein L9 30S ribosomal subunit protein S20
30S ribosomal subunit protein S5 50S ribosomal subunit protein L21 50S ribosomal subunit protein L10 30S ribosomal subunit protein S21
30S ribosomal subunit protein S6 50S ribosomal subunit protein L22 50S ribosomal subunit protein L11 30S ribosomal subunit protein S22
30S ribosomal subunit protein S7 50S ribosomal subunit protein L23 50S ribosomal subunit protein L13 50S ribosomal subunit protein L1
30S ribosomal subunit protein S8 50S ribosomal subunit protein L24 50S ribosomal subunit protein L14 50S ribosomal subunit protein L2
30S ribosomal subunit protein S9 50S ribosomal subunit protein L25 50S ribosomal subunit protein L15 50S ribosomal subunit protein L3
30S ribosomal subunit protein S10 50S ribosomal subunit protein L27 50S ribosomal subunit protein L16 50S ribosomal subunit protein L4
30S ribosomal subunit protein S11 50S ribosomal subunit protein L28 50S ribosomal subunit protein L32 30S ribosomal subunit protein S13
30S ribosomal subunit protein S12 50S ribosomal subunit protein L29 50S ribosomal subunit protein L33 30S ribosomal subunit protein S14
50S ribosomal subunit protein L35 50S ribosomal subunit protein L30 50S ribosomal subunit protein L34 30S ribosomal subunit protein S15
50S ribosomal subunit protein L36 50S ribosomal subunit protein L31 30S ribosomal subunit protein S16  
Ribosomal RNAs
Protein name Protein name Protein name  
23S rRNA 5S rRNA 16S rRNA  
bulk tRNAs
Protein name Protein name Protein name Protein name
tRNAalaT tRNAmetT tRNAglyX tRNAglnX
tRNAalaU tRNAmetU tRNAglyY tRNAgltT
tRNAalaV tRNAmetV tRNAhisR tRNAgltU
tRNAalaW tRNAmetW tRNAileT tRNAgltV
tRNAalaX tRNAmetY tRNAileU tRNAgltW
tRNAargQ tRNAmetZ tRNAileV tRNAglyT
tRNAargU tRNApheU tRNAileX tRNAtyrU
tRNAargV tRNApheV tRNAileY tRNAtyrV
tRNAargW tRNAproK tRNAleuP tRNAvalT
tRNAargX tRNAproL tRNAleuQ tRNAvalU
tRNAargY tRNAproM tRNAleuT tRNAvalV
tRNAargZ tRNAsec tRNAleuU tRNAvalW
tRNAasnT tRNAserT tRNAleuV tRNAvalY
tRNAasnU tRNAserU tRNAleuW tRNAvalZ
tRNAasnV tRNAserV tRNAleuX tRNAglyU
tRNAasnW tRNAserW tRNAleuZ tRNAglyV
tRNAaspT tRNAserX tRNAlysQ tRNAglyW
tRNAaspU tRNAthrT tRNAlysT tRNAglnV
tRNAaspV tRNAthrU tRNAlysV tRNAglnW
tRNAcysT tRNAthrV tRNAlysW tRNAtrpT
tRNAglnU tRNAthrW tRNAlysY tRNAtyrT
tRNAlysZ tRNAvalX    

Table 1: E. coli IVTT components.

The PURE system represents an important step towards a totally defined in vitro transcription/translation system, thus avoiding the “black box” nature of the cell extract. The immediate advantage is the significantly reduced level of all contaminating activities. The PURE system has the capacity for a yield of more than 100 μg/ml is today exclusively licensed to New England Biolabs (Ipswich, MA, USA) under the trade-name “PURExpress” [20]. Moreover the E. coli IVTT lysate, respect the RRL one, is totally characterized, which could be an advantage for the subsequent analysis of the results.

The presence of “background” molecules, in fact, represents the main obstacle to the data interpretation and bioinformatic tools are necessary to improve them. For this reason new matching software have been implemented. SpADS [21] an R [22] implementation of preprocessing algorithms for data reduction and noise suppression was used in order to filter results from background noise i.e. master mix MS spectrum. Moreover, this latter was used coupled to and R implementation of the K Means clustering [23,24].

The MS samples were realized printing SNAP-NAPPA spots on gold coated glass slides in a special geometry, getting proteins with higher density, in order to obtain an amount of protein appropriate for MS analysis. The spots of 300 microns were printed in 12 boxes. The spots in a box were of the same gene and the sample genes immobilized - all genes with a central role in cell signalling [25-29] - were:

p53_Human, Cellular tumor antigen p53;

CDK2_Human, Cyclin-dependent kinase 2;

Src_Human-SH2, the SH2 domain of Proto-oncogene tyrosineprotein kinase;

PTPN11_Human-SH2, the SH2 domain of Tyrosine-protein phosphatase non-receptor type 11.

The spots in a box were of the same gene, and in particular one box apiece was reserved to the sample genes, two boxes were negative controls and reference samples, and six boxes, were printed with the sample genes in an order blinded to the researcher who made MS analysis. The presence of background molecules in fact represents the main obstacle in the MS data interpretation and bioinformatics tools are mandatory to improve their subtraction with new matching software being recently implemented and optimised [22].

Materials and Methods

Production and expression of NAPPA

The full length cDNA for p53 (MW 43.80 kDa), CDK2 (MW 33.93 kDa) - both purchased form DNAsu plasmid repository of the Biodesign Institute, Arizona State University - and the SH2 domain of Src (MW 25.95 kDa) and PTPN11 (MW 13.13 kDa) - both purchased from Open Biosystem, Thermo Scientific- were amplified and cloned into NdeI and XhoI sites in pCOATexp SNAPf vector [30], a derivative of pCOATexp and pSNAPf (New England Biolabs, Ipswich, MA, USA). Plasmid DNA was purified with NucleoBond® Xtra Maxi (Macherey- Nagel Inc., Bethlehem, PA, USA) and re suspended in water.

Printing mix was prepared with 0.66 μg/μl DNA, capture reagent (BG-PEG-NH2 ranging from 80 to 800 μg/μl; New England Biolabs, Ipswich, MA, USA), protein cross-linker (2.2 mM BS3; Pierce, Rockford, IL, USA) and BSA (3.6 μg/μl; Sigma-Aldrich). As negative controls were prepared in printing mix solution without DNA (hereafter named master mix, MM). Similar to the gene samples, negative controls were prepared with a concentration range from 80 to 800 μg/μl of SNAP capture reagent.

As a positive control (for fluorescence analysis) mouse IgG or rabbit IgG (Pierce, Rockford, IL, USA) were added in a printing mix instead of DNA. Samples were agitated for 90 minutes at 1200 rpm in RT and printed in glass slides (VWR International, Radnor, PA, USA), which were previously coated for 10 minutes with 2% solution of 3-Aminopropyltriethoxysilane (Pierce, Rockford, IL, USA) in acetone, rinsed in acetone and dried with filtered air.

All samples were printed on a 50 nm gold coated glass slides (Phasis, Switzerland) to allow MALDI-TOF MS analysis, using a Genetix QArray2 with 300 μm solid stealth technology pins (Arrayit Corporation, Sunnyvale, CA, USA). Arrays were stored in an airtight container at room temperature until use.

The printed slides were expressed using a reconstituted E. coli coupled cell-free expression system (E. coli IVTT) (PURExpress in vitro system, New England Biolabs, Ipswich, MA, USA) [14,31]); briefly, slides were blocked in SuperBlock (Thermo Scientific, Rockford, IL, USA) for 1hour at room temperature with constant agitation and dried with filtered air. HybriWells gaskets (Grace Biolabs, Bend, OR, USA) were applied on the top of the slides and 160μl of E. coli IVTT, prepared according to the manufacturers’ instructions, was added.

Slides were incubated for 90 minutes at 30°C and 30 minutes at 15°C. For fluorescence analysis the slides were incubated for one hour of blocking/washing with PBSTM (1X PBS supplemented with 0.2% Tween 20 and 5% Milk). The levels of protein expression were assayed with anti-SNAP antibody (New England Biolabs, Ipswich, MA, USA) or anti-p53 antibody (Santa Cruz Biotechnology, Inc.; Santa Cruz, CA, USA), followed by secondary antibodies labelled with cy3 (Jackson ImmunoResearch Laboratories, Inc.; West Grove, PA, USA). All antibodies incubations were performed in a 1:300 dilution in PBSTM at RT, with agitation for one hour.

NAPPA slides quantification and data analysis

Slide images were obtained with PowerScanner (Tecan Group Ltd., Männedorf, Switzerland) and the signal intensity was quantified using the Array-ProAnalyzer 6.3 (Tecan Group Ltd., Männedorf, Switzerland), using the default settings. The median intensity across the quadruplicates was measured and the background was corrected through the subtraction of the median value of the negative control with a matching SNAP concentration (Figure 1).

MS analysis

The MS samples were realized printing SNAP-NAPPA spots of 300 microns in 12 boxes of 7×7 or 10x10 spots per box (spaced of 350 microns, centre to centre). The spots in a box were of the same gene, and in particular one box apiece was reserved to the sample genes (p53, CDK2, Src-SH2 and PTPN11-SH2), two boxes were printed with MM as negative control and reference samples, and six boxes, labelled with the letters from A to F, were printed with the sample genes in an order blinded to the researcher who made MS analysis (Figure 2).

nanomedicine-nanotechnology-experimental-set-up

Figure 2: Experimental set-up. Samples were printed on a gold coated glass slides; the array printing was realized in a special geometry for MS analysis. The spots of 300 microns were printed in 12 boxes of 7×7 or 10x10 (spaced of 350 microns, centre to centre). The spots in a box were of the same gene: four boxes were printed with sample genes (p53, CDK2, Src-SH2 and PTPN11-SH2), two boxes were printed with master mix (MM) as negative control and reference samples, and six boxes, labelled with the letters from A to F, were printed with the sample genes in an order blinded to the researcher. SNAPNAPPAs were analyzed by LC-ESI and MALDI-TOF MS. We utilized two MALDI-TOF MSs, a Voyager and a Bruker MS. For LC-ESI MS and Voyager MS analysis the sample were collected at the end of trypsin digestion and stored liquid in Eppendorf tubes since the analysis. For Bruker MS analysis the matrix was mixed with the trypsin digested fragment solutions directly on the slides and let to dry before the analysis.

This configuration allowed us to identify the samples named A, B, C, D, E and F (named “blinded samples”) matching their experimental mass lists with those of the known samples (p53, CDK2, Src-SH2 and PTPNII-SH2) and then to proceed with the identification by peptide mass fingerprint (through data bank search) to further confirm the results.

The analyses were performed using two different MALDI-TOF mass spectrometers, a Voyager-DE STR (Applied Biosystems, Framingham, MA, USA) and an Ultraflex III (Bruker Daltonics, Leipzig, Germany) (that represents an updated version of the Bruker Autoflex utilized in our previous research [5], and a LC-ESI MS.

For MS analysis, after the incubation, the slides were washed with PBS NaCl (1X PBS with 500 mM NaCl) three times and dried with nitrogen. The proteins synthesized on the NAPPA were trypsin digested: each box (of 16 spots) was overlaid with 5 μl of 0.01 mg/ml trypsin (Trypsin Gold, Mass Spectrometry Grade, Promega, Madison, WI, USA) in 25 mM ammonium bicarbonate (pH 7.5) and incubated in a humid chamber at 37°C for 4 hours [32,33]. At the end of the digestion the tryptic digested solutions were collected and stored in Eppendorf tubes at 4°C for the LC-ESI and Voyager MALDI-TOF MS analysis or the solvent was let evaporating at RT and the slides were stored at 4°C for Ultraflex III MALDI-TOF MS analysis.

For LC-ESI MS analysis, peptide mixtures were analyzed by nanoflow reversed-phase liquid chromatography tandem mass spectrometry (RPLC- MS/MS) using an HPLC Ultimate 3000 (DIONEX, Sunnyvale, CA U.S.A) connected on line with a linear Ion Trap (LTQ, ThermoElectron, San Jose, CA). Peptides have been desalted in a trap column (Acclaim PepMap 100 C18, LC Packings, DIONEX) and then separated in a reverse phase column, a 10 cm long fused silica capillary (Silica Tips FS 360-75-8, New Objective, Woburn, MA, USA), slurry-packed in-house with 5 μm, 200 Å pore size C18 resin (Michrom BioResources, CA).

Peptides were eluted using a linear gradient from 96% A (H2O with 5% acetonitrile and 0.1% formic acid) to 60%B (ACN with 5% H2O and 0.1% formic acid) in 40 min, at 300 nl/min flow rate. Analyses were performed in positive ion mode and the HV Potential was set up around 1.7-1.8 kV. Full MS spectra ranging from m/z 400 to 2000 Da were acquired in the LTQ mass spectrometer operating in a data-dependent mode in which each full MS scan was followed by five MS/MS scans where the five most abundant molecular ions were dynamically selected and fragmented by collision-induced dissociation (CID) using a normalized collision energy of 35%. Target ions already fragmented were dynamically excluded for 30 s.

Tandem mass spectra were matched against Swiss Prot database and through SEQUEST algorithm [34] incorporated in Bioworks software (version 3.3, Thermo Electron) using fully tryptic cleavage constraints with the possibility to have one miss cleavage permitted, static carbamidomethylation on cysteine residues and methionine oxidation as variable modification. Data were searched with 1.5 Da and 1 Da tolerance respectively for precursor and fragment ions. A peptide has been considered legitimately identified when it achieved cross correlation scores of 1.8 for [M+H]1+, 2.5 for [M+2H]2+, 3 for [M+3H]3+, and a peptide probability cut-off for randomized identification of p<0.001.

For Voyager MALDI-TOF MS analysis, since the Voyager target is too small to carry a NAPPA slide, 1 μl of sample (collected from the array surface) was spotted on a standard Voyager target, then 1 μl of α-cyano-4-hydroxy-cinnamic acid (HCCA, Bruker Daltonics Leipzig, Germany) saturated solution in 0.1% trifluoroacetic acid / acetonitrile (2:1) (matrix solution) was added and finally this solution was let dry. The instrument operated in the delayed extraction mode.

Peptides were measured in the mass range from 750 to 4000 Da; all spectra were internally calibrated using peaks from trypsin autoproteolysis and processed via the Data Explorer software. Proteins were unambiguously identified by searching a comprehensive nonredundant protein database (Swiss Prot) using the program Mascot (https://www.matrixscience.com). Search settings allowed one missed cleavage with the trypsin enzyme selected, oxidation of methionine as variable modification, carboamidomethylation of cysteine as fixed modifications, peptide tolerance of 50 ppm, all taxa.

For Ultraflex III MALDI-TOF MS each box was overlaid with 2.5 μl of HCCA matrix solution and let it dry. To calibrate the spectra we spotted on the array surface 1 μl of peptide calibration standard solution (Bruker Daltonics, Leipzig, Germany) in HCCA matrix solution.

The MALDI-TOF measures were performed in reflectron mode; the resulting mass accuracy for protein was <50 ppm. MALDI-TOF mass spectra were acquired with a pulsed nitrogen laser (337 nm) in positive ion mode. The algorithm used for spectrum annotation was “Sophisticated Numerical Annotation Procedure” (SNAP). This process used the following detailed metrics: Peak detection algorithm, SNAP; Signal to noise threshold, 10; Relative intensity threshold, 10%; Greatest number of peaks, 100; Quality factor threshold, 100; SNAP average composition, Averaging. Peaks in the mass range of m/z 600-3000 were used for the peptide mass fingerprint.

For MASCOT data bank search we utilized Biotools software v2.2 (Bruker Daltonics, Leipzig, Germany), that allowed automated protein identification via library search with fully integrated MASCOT software v2.2.06 (Matrix Sciences, Ltd., London, U.K.) that searches against the Swiss-Prot/ TrEMBL database. The following parameters were used for the search: Homo sapiens or Bacteria; tryptic digest with a maximum of 1 missed cleavage; eventual methionine oxidation and a mass tolerance of 50 ppm. Identification was accepted based on significant MASCOT Mowse scores (p<0.05).

In order to identify the blinded protein panel (A, B, C, D, E and F), we used SpADS an R package for MS data preprocessing coupled to and R implementation of the K Means clustering SpADS and K Means clustering application on two specimen of 23 and 56 sample respectively was performed, the former composed of only known proteins (p53, CDK2, Src-SH2 and PTPN11-SH2) spectra while the latter composed of all spectra (the same specimen plus A,B,C,D,E,F spectra).

After a first manual selection, in which out layers were deleted from this specimen, a SpADS pre-processing was applicated. Pre-processing consist of different operation on the whole spectra or in a selected region, in this case a peak extraction, with a binning window selection was performed. Selected regions of interest (ROI) were selected between 1000/2000 and on 1000/1200 on mZ axis. After pre-processing clustering was performed. Binning windows were selected dependently on this latter ROI, in the former case a binning window of 1000 was used and in the latter a binning window of 500 was used in order to preserve data consistency from flattening.

The experimental mass lists of the blinded panel were matched with those of the known samples (p53, CDK2, SH2-Src and SH2-PTPN11). The same algorithm was used to subtract MM peaks to the other spectra in order to obtain a mass list containing only the peaks obtained from protein digestion.

Results and Discussion

Fluorescence analysis

To verify the proper protein expression and capture on SNAPNAPPA a preliminary test has been leaded by fluorescence analysis. The same SNAP-NAPPA samples employed for MS analysis (p53, CDK2, SH2-Src and SH2-PTPN11) were spotted on microscope glass in a 2×2 spots per box configuration using increasing SNAP concentrations (Figure 2). As negative control on the gold slides was printed a box only with master mix (Figures 1 and 2), while the positive controls mouse IgG and rabbit IgG were added in a printing mix instead of DNA.

Proteins were synthesized by two different IVTT systems, a new system extracted from human cells (1-Step Human Coupled IVT, HCIVT, Thermo Scientific) and E. coli IVTT. It is known [14] that HCIVT performs better than RRL IVTT. The yield of protein synthesized in HCIVT is more than 10 times higher than RRL. Moreover, HCIVT showed a robust lot-to-lot reproducibility. In immune assays, the signals of many antigens were detected only in HCIVT-expressed arrays, mainly due to the reduction in the background signal and the increased levels of protein on the array [14,35]. The protein yields obtained through PURE system has then been matched to that obtained with this innovative cell free IVTT system.

In Figure 1 are reported the images of three SNAP-NAPPA slides after proteins expression fluorescence acquired. Two slides were expressed with HCIVT and a third with E. coli IVTT; the level of protein displayed on the array was measured using respectively anti-SNAP antibody or anti –p53 antybody followed by a cy3-labeled secondary antibody.

The results obtained not only confirmed the proper protein expression and capture on the array surface but, moreover, demonstrated that E. coli IVTT systems ensured a protein yield form 2 to 8 times higher respect HCIVT, considering the higher SNAP concentration. The gain respect RRL is, therefore, more than twenty times.

MALDI-TOF mass spectrometry

We analyzed by MALDI-TOF MS four copies of SNAP-NAPPA slides with 7×7 spots per box (two by Voyager-DE STR and two by Ultraflex III), and four copies of slides with 10×10 spots per box (two by Voyager-DE STR and two by Ultraflex III). The results were extremely reproducible both with respect to 7×7 spots/box and 10x10 spots/ box that with respect to the different spectrometers and no significant difference was appreciable (Figures 2-6).

nanomedicine-nanotechnology-p53-sample-spectrum

Figure 3: a) P53 sample spectrum obtained by Voyager MS. MASCOT data-bank results: (b) elongation factor EFTU and (c) albumin bovin present respectivly in the lysate and on the array surface.

nanomedicine-nanotechnology-experimental-autoflex

Figure 4a: Experimental mass list of CDK2 (ultraflex data) and experimental mass list [MM+ lysate] (ultraflex data) on the top. ROI selection 1000/1200 of spectra as obtained by Bruker Autoflex MS.

nanomedicine-nanotechnology-cdk2-sample-homologous

Figure 4b: CDK2 sample spectrum obtained by Voyager MS. MASCOT data-bank results: highlighted by red arrow is the homologous kinase (CSK2) proteins found.

nanomedicine-nanotechnology-samples-mass-spectra

Figure 5: Samples mass spectra acquired by Ultraflex III MS. Each one of this spectrum is the sum of 100 single shot spectrum a) full range; b) 1.1 - 2.4 kDa range.

nanomedicine-nanotechnology-ultraflexiii-samples

Figure 6: UltraflexIII samples mass spectra summation. The arrows point at the theoretical peak position.

We conducted two parallel identifications, the first through the matching algorithm comparing blinded and known samples experimental mass lists, and the second submitting experimental mass lists to databank search.

We submitted the experimental mass list obtained for the known samples (p53, CDK2, Src-SH2 and PTPN11- SH2) to MASCOT data bank search. The MASCOT searching engine uses the Mowse scoring algorithm [36] to determine the significance of the peptide fingerprint result. Protein score is -10*Log(P), where P is the probability that the observed match is a random event. Protein scores greater than 64 are significant (p<0.05).

In Table 2 are summarized the results obtained with significant scores; in all the samples has been detected with a significant score also the BSA (belonging to MM), that has not been reported in Table 2 for simplicity.

Sample Protein identified Score
p53 EFTU1 (elongation factor) – E. coli 74
CDK2 IF3_SALTI, Translation initiation factor IF-3 - E. coli 73
PTPN11-SH2 IF3_SALTI, Translation initiation factor IF-3 - E. coli 72
SRC-SH2 SYM_STRAW, Methionine--tRNA ligase - E. coli 82

Table 2: MASCOT data-bank search results synthesis (about MALDI-TOF data).

LC-ESI mass spectrometry

We analyzed by LC-ESI two copies of 10×10 spots/box slides. The data obtained resulted very reproducible, too. The matching of the results in human database allowed us to identify with a good score albumin (ALBU_HUMAN Serum albumin), presumably due to some peptides that are common also to BSA. No other human proteins were identified. We preformed a search against bacterial database; for all the samples we identified approximately the same proteins (essentially from bacterial lysate); the results are reported in Table 3.

Protein Accession Score
IF2_CITK8 Translation initiation factor IF-2 A8AQ58 300
DNAK_CITK8 Chaperone protein dnaK A8ALU3 160
IF1_CITK8 Translation initiation factor IF-1 A8AIJ9 153
RL22_AGGAC 50S ribosomal protein L22 P55838 141
EFTS_CITK8 Elongation factor Ts A8ALC0 136
EFTU_ENTS8 Elongation factor Tu A7MKI5 132
RPOL_BPT7 DNA-directed RNA polymerase P00573 122
RPOL_BPT3 DNA-directed RNA polymerase P07659 114
|OMPA_CITFR Outer membrane protein A (Fragment) P24016 112
RL16_CITK8 50S ribosomal protein A8AQK9 111
RPOL_BPK11 DNA-directed RNA polymerase P18147 108
RL5_CITK8 50S ribosomal protein L5 A8AQK4 107
RL14_CITK8 50S ribosomal protein L14 A8AQK6 103
DNAK1_PHOPR Chaperone protein DnaK 1 Q6LUA7 103
RS2_CITK8 30S ribosomal protein S2 A8ALC1 101
IF2_CITK8 Translation initiation factor IF-2 A8AQ58 100
IF1_NITOC Translation initiation factor IF-1 Q3J7Z5 92
IF1_CITK8 Translation initiation factor IF-1 A8AIJ9 80
RS4_CITK8 30S ribosomal protein S4 A8AQJ1 89
IF2_PECCP Translation initiation factor IF-2 C6DKK3 86
RL4_CITK8 50S ribosomal protein L4 A8AQL8 79
RS9_CITK8 30S ribosomal protein S9 A8AQC0 76
EFTU_BRELN Elongation factor Tu P42471 75
EFTU1_PHOPR Elongation factor Tu 1 Q6LVC0 70
EFTU_BACFN Elongation factor Tu Q5L890 70
EFTU_ENTS8 Elongation factor Tu A7MKI5 70
RL16_CITK8 50S ribosomal protein L16 A8AQK9 70
EFTU_BDEBA Elongation factor Tu Q6MJ00 67
RS3_CITK8 30S ribosomal protein S3 A8AQL0 60
DNAK1_PHOPR Chaperone protein dnaK 1 Q6LUA7 59
RL32_CROS8 50S ribosomal protein L32 A7MFQ6 49
RS7_CROS8 30S ribosomal protein S7 A7MKJ3 49
EFTU_SOLUE Elongation factor Tu Q01SX2 46
IF1_PHOPR Translation initiation factor IF-1 Q6LT12 45
RL6_CITK8 50S ribosomal protein L6 A8AQK0 42

Table 3: LC-ESI MS results for bacterial database matching.

MALDI-TOF data analysis

Both MALDI-TOF and LC-ESI data identified essentially proteins from SNAP-NAPPA chemistry and from bacterial lysate. These results were not surprising considering the high complexity of the samples analyzed and considering that the concentration of the proteins expressed and captured on the array is, at least in solution; hundred times lower than those of E. coli lysate components.

From Shimizu and co-workers results [18] we know that the PURE system components concentrations are in the range 1.5-40 μg/μl while the proteins are expressed in a concentration of about 0.10 μg/μl. evidently, even if after proteins synthesis and capture the slides have been carefully washed, some lysate proteins remained a specifically bounded on the slide gold surface. The presence of these “background” molecules represents the main obstacle to the samples identification and we experienced different paths to overcome this obstacle.

Exploiting the data obtained form MM samples analysis we subtracted - the MM experimental mass list to those of known samples and performed a further MASCOT data bank search. Again no significant identifications were obtained.

One of the main advantages of PURE system, that prompted us to use it, is that its components are all recombinant proteins, so all known and well characterized. Thanking advantage of this aspect we built a data bank of all the theoretical mass lists belonging to PURE system recombinant proteins and subtracted them from the experimental mass lists of known samples. The samples protein identification was not possible again.

A further aspect to take in account when analyzing MS data is that the proteins immobilized on the SNAP-NAPPA were synthesized with a SNAP tag and a FLAG tag that could also contribute to the difficulty in matching spectra with databases that are based on tryptic digests of natural proteins. It was then useful to consider strategies that compensate for this; we modified the sequence of sample proteins present in the reference database, adding the tags.

We used these modified sequences to perform a new fingerprint: the theoretical mass lists of the chimeras after in silico trypsin digestion were obtained by means of the software Sequence Editor included into the Biotools package. We matched the experimental mass lists with these theoretical mass lists. The peaks identified are reported in Table 4 together with the chimera proteins sequence (underlined the fragment identified). The peptides of SNAP tag are in italic and those of FLAG tag in bold italic. The sequence coverage was calculated as the ratio between the number of residues matched and the total number of protein residues (Table 4).

Match to: SNAP-CDK2_human-FLAG
Number of mass values searched: 65
Number of mass values matched: 8
Sequence Coverage: 22.4%
Percentage of experimental masses matched (with background peaks): 12.3%
1     MKNDKDCEMK  RTTLDSPLGK   LELSGCEQGL    HRIIFLGKGT    SAADAVEVPA  PAAVLGGPEP  LMQATAWLNA YFHQPEAIEE
81    FPVPALHHPV     FQQESFTRQV   LWKLLKVVKF GEVISYSHLA   ALAGNPAATA  AVKTALSGNP VPILIPCHRV      VQGDLDVGGY 
161 EGGLAVKEWL    LAHEGHRLGK  PGLGMENFQK VEKIGEGTYG  VVYKARNKLT GEVVALKKIR   LDTETEGVPS   TAIREISLLK
241 ELNHPNIVKL       LDVIHTENKL   YLVFEFLHQD   LKKFMDASAL TGIPLPLIKS      YLFQLLQGLA  FCHSHRVLHR DLKPQNLLIN
321 TEGAIKLADF       GLARAFGVPV  RTYTHEVVTL  WYRAPEILLG   CKYYSTAVDI   WSLGCIFAEM  VTRRALFPGD SEIDQLFRIF
401 RTLGTPDEVV      WPGVTSMPDY KPSFPKWARQ  DFSKVVPPLD   EDGRSLLSQM   LHYDPNKRIS   AKAALAHPFF QDVTKPVPHL
481 RLDYKDDDDK
IDENTIFIED FRAGMENTS
Range Theoretical Experimental DELTA Sequence
[290-306] 2019.015 2019.148 0.133 SYLFQLLQGLAFCHSHR
[311-326] 1765.994 1765.922 0.072 DLKPQNLLINTEGAIK
[274-289] 1685.943 1685.995 0.052 FMDASALTGIPLPLIK
[260-272] 1663.897 1663.991 0.094 LYLVFEFLHQDLK
[191-204] 1540.814 1540.742 0.072 VEKIGEGTYGVVYK
[221-234] 1487.747 1487.939 0.192 LDTETEGVPSTAIR
[435-444] 1095.556 1095.571 0.015 VVPPLDEDGR
[11- 20] 1086.603 1086.569 0.034 RTTLDSPLGK
Match to: SNAP- p53 – FLAG
Number of mass values searched: 62
Number of mass values matched: 3
Sequence Coverage: 6.3%
Percentage of experimental masses matched: 4.8%
1     MKNDKDCEMK  RTTLDSPLGK    LELSGCEQGL    HRIIFLGKGT   SAADAVEVPA  PAAVLGGPEP  LMQATAWLNA  YFHQPEAIEE
81    FPVPALHHPV     FQQESFTRQV   LWKLLKVVKF  GEVISYSHLA  ALAGNPAATA  AVKTALSGNP  VPILIPCHRV     VQGDLDVGGY 
161 EGGLAVKEWL   LAHEGHRLGK  PGLGMEEPQS   DPSVEPPLSQ   ETFSDLWKLL   PENNVLSPLP    SQAMDDLMLS PDDIEQWFTE
241 DPGPDEAPRM    PEAAPRVAPA   PAAPTPAAPA   PAPSWPLSSS   VPSQKTYQGS   YGFRLGFLHS   GTAKSVTCTY   SPALNKMFCQ
321 LAKTCPVQLW   VDSTPPPGTR   VRAMAIYKQS   QHMTEVVRRC PHHERCSDSD  GLAPPQHLIR    VEGNLRVEYL   DDRNTFRHSV
401 VVPYEPPEVG   SDCTTIHYNY    MCNSSCMGGM  NRRPILTIIT      LEDSSGNLLG   RNSFEVRVCA   CAGRDRRTEE  ENLRKKGEPH
481 HELPSGSTKR ALPNNTSSSP       QPKKKPLDGE    YFTLQIRGRE    RFEMFRELNE   ALELKDAQAG KEPGGSRAHS   SHLKSKKGQS
516 TSRHKKLMFK TEGPDSDLDY    KDDDDK 
IDENTIFIED FRAGMENTS
Range Theoretical Experimental DELTA Sequence
[491-504] 1467.768 1467.817 0.049 ALPNNTSSSPQPKK
[542-554] 1361.680 1361.786 0.106 EPGGSRAHSSHLK
[ 11- 20] 1086.603 1086.663 0.060 RTTLDSPLGK

Table 4: Results of the matching of CDK2 and p53 samples experimental mass lists with the theoretical mass list obtained from the trypsin digestion of the sequence of native proteins plus SNAP tag and FLAG tag. After matching results there are reported the sequences of the chimera proteins: the peptides of SNAP tag are in black, those of native protein in red and those of FLAG tag in blue. The sequence coverage is calculated as the ratio between the number of residues matched and the total number of protein residues.

The results obtained allow us to identify CDK2 sample with a percentage of sequence coverage of 22% and sample p53 with a percentage of sequence coverage of 6% for p53 while for -SRC-SH2 and PTPN11- SH2 samples no fragments were identified.

The results obtained from SNAP-NAPPA analysis seem worse if compared with those relative to the NAPPA presented in our previous study [5]. In the previous research the MASCOT databases search also turned out a difficult task, but considering the chimeras sequences we obtained percentages of coverage between 20% and 40%.

Matching algorithM

In parallel to known samples identification trough MASCOT databank search we developed a matching algorithm to match known and unknown samples.

In order to evaluate the goodness of SpADS preprocessing on SNAP/ MS spectra, single spectrum routines of SpADS were used to preprocess data and view results of their application on SNAP/MS protein Spectra. Some tests were performed in order to recognize protein spectra, in particular two main tests were performed for each protein: the former is performed on a “region of interest” (ROI) between 1000 and 2000 mZ while the latter was performed on the whole spectra. After region selection noise subtraction of the mastermix+lysate spectrum was applied too.

A specimen of four different proteins was used for these tests, as in the following:

• CDK2

• PTPN11-SH2

• Src-SH2

• p53

Tests were conducted applying different binning windows for peak extraction this means that each spectrum was preprocessed with a binning window of 10, 100 and 1000 m/Z values. The same conditions were applied for both spectra preprocessed with and without ROI selection. Finally, in order to overcome noise troubles a threshold of 400, over the Intensity axes, was applied to every protein spectrum.

SpADS is able to provide results, of the so far discussed preprocessing functions, in an ASCII file. The found peaks were submitted to MASCOTT and results are showed in figures.

In a ROI between 1000 and 1200 Da was selected in order to highlight differences in spectra. These tests were performed as previously described for two protein spectra i.e. CDK2 and p53. For the former a homologous result was found, indeed CSK2, a casein kinase appears in Figure 5. Similar results are apparent also by processing the p53 protein MS spectra (not shown).

Clustering

Clustering proposed solutions are showed in Figures 8 and 9 for the “only protein” specimen with a ROI selection of 1000/2000 and 1000/1200 respectively. The same results are shown in related Tables 5 and 6. While results for the ROI 1000/2000 are cluster overlapped and hard to investigate using a restricted ROI of 1000/1200 and a more precise sampling approach clusters are suitable and understandable without any further software intervention. In order to compare results, the same processing was then performed for the second specimen, composed of the 56 spectra with known and unknown proteins. In order to couple these unknown samples with the right protein spectra, preprocessing and clustering algorithms were then run. As in the previous test results cluster for ROI 1000/2000 results in overlapped ensembles hard to evaluate, for this reason this latter is not shown while results are shown for clustering of specimen in region 1000/1200, Figure 10 and related Table 7 (Tables 7 and 8).

nanomedicine-nanotechnology-spads-clustering-23-protein

Figure 7: SpADS and Clustering solution for a specimen of 23 protein samples of raw data. Only binning preprocessing function was performed before cluster analysis run on the ROI 1000/2000, as obtained by Bruker Autoflex MS.

nanomedicine-nanotechnology-spads-clustering-23-protein

Figure 8: SpADS and Clustering solution for a specimen of 23 protein samples of raw data. Only binning preprocessing function was performed before cluster analysis run on the ROI 1000/1200, as obtained by Bruker Autoflex MS.

nanomedicine-nanotechnology-spads-clustering-56-protein

Figure 9: SpADS and Clustering solution for a specimen of 56 protein samples of raw data. Only binning preprocessing function was performed before cluster analysis run on the ROI 1000/1200 as obtained by Bruker Autoflex MS.

Cluster Assignment
p53 (p) 2 2 1 1
PTPN11-SH2(pt) - 2 2 2
Src-SH2 (s) - 3 1 1
CDK2 (c) 3 - 2 1

Table 5: Cluster assignment for each known protein sample on a specimen of 23 samples in the ROI 1000/2000 with a binning window of 1000 m/Z. Statistics are based on the SpADS results coupled with K Means clustering given in Figure 8.

Cluster Assignment
Cluster Number 1 2 3 4
P53 (p) 2 3 1 -
PTPN11-SH2 (pt) 3 - - 3
Src--SH2 (s) 3 1 1 -
CDK2 (c) - 1 2 3

Table 6: Cluster assignment for each known protein sample on a specimen of 23 spectra in the ROI 1000/1200 with a binning window of 500 m/Z. Statistics are based on the SpADS results coupled with K Means clustering given in Figure 9.

Cluster Assignment
Cluster Number 1 2 3 4
P53 (p) 1 1 4 (66%) -
PTPN11-SH2 (pt) 3 3 (50%) - -
Src-SH2 (s) - 3 1 1 (20%)
CDK2 (c) 2 (33%) 1 3 -
A = Src – SH2* 1 2 - 3 (50%)
B = cdk2 2 (40%) 2 - 1
C = p53 4 - 1(20%) -
D = PTPN11-SH2 1 2 (20%) 2 -
E = PTPN11-SH2 - 4 (100%) - -
F = PTPN11-SH2 2 4 (50) 1 1

Table 7: Cluster assignment for each known protein sample on a specimen of 56 spectra. Statistics are based on the SpADS results coupled with K Means clustering given in figure 10. In bold assignment of clusters by human interpretation of cluster results. Highlited with * striking recognition.

Unknown Assignemnt
Unknown Samples Actual Festa Deposition Via Cluster analysis
A Src – SH2 Src – SH2
B cdk2 cdk2
C p53 p53
D PTPNII-SH2   PTPN11-SH2
E Src – SH2 PTPN11-SH2
F p53 PTPN11-SH2

Table 8: Comparison between the actual protein deposition in the NAPPA array and the assignment made by cluster analysis as explained in the text and in Table 7.

The results obtained on the unknown assignment (Table 8) through the bioinformatic processing, appears striking without any further human intervention.

Conclusions

We have here presented our analysis of SNAP-NAPPA, an improved version of NAPPA with a SNAP tag, expressed with a novel cell-free transcription/translation system reconstituted from the purified components necessary for E. coli translation, the PURE system [20], and analyzed by fluorescent label and by label-free Mass Spectrometry.

The fluorescence analysis carried out demonstrated not only the proper SNAP-NAPPA behaviour but also that E. coli IVTT systems ensured a protein yield about 20 times higher respects RRL (Figure 1).

The Mass Spectrometry coupled with ad hoc implemented bioinformatics, as it was expected due to the high complexity of the NAPPA-SNAP system, gave quite encouraging results improving earlier findings with MS without SNAP (5) were very complex and a bioinformatics tool has been developed ad hoc for their analysis [21]. The MS samples were realized printing SNAP-NAPPA spots on gold coated glass slides in a special geometry in order to obtain an amount of protein appropriate for MS analysis.

The samples were printed in 12 boxes of 7×7 spots per box. One box apiece was reserved to the sample genes (p53, CDK2, SH2-Src and SH2-PTPN11), two boxes were negative controls (MM) and reference samples, and six boxes, were printed with the sample genes in an order blinded to the researcher who made MS analysis. We conducted two parallel identifications, the first through the matching algorithm comparing blinded and known samples experimental mass lists, and the second submitting experimental mass lists to databank search.

The databank search of samples experimental mass lists obtained by MALDI-TOF or LC-ESI-MS provided the identification, with significative scores, of molecules of MM or E. coli lysate (Figure 3). Then different strategies have been addressed to overcome the presence of these “background” molecules that represented the main obstacle to the samples identification. Experimental master mix plus E. coli lysate mass lists have been subtracted to samples experimental mass lists and the results have been submitted to MASCOT databank search. Unfortunatly this strategy did not give statistically significative results on MS of these SNAP NAPPA array, with the best identification being 22% for CDK2 sample (Figure 3) and poor clustering even on known proteins (Figure 7), apparently worse if compared with those relative to the old MS NAPPA version and presented in Spera et al. [5].

Deciding to postpone now the lengthy subtraction of the theoretical values of all lysate recombinant E. coli components ( work still in progress), we pursue then the coupling of our newly developed software SpADS [21] to K Means Cluster algorithm with good results both for known (Figure 8) and unknown (Figure 9) protein indentification, up to 67% correct score, quite better than earlier MS without SNAP.

A conservative rule of thumb suggest that with at least hundred times more MS spectra of the unknown protein (a minimum of hundred rather than 1 as was in the limiting worst case and rather than 8 in the best case). The results so far obtained are thereby encouraging even with a quite low number of MS spectra so far acquired and without the subtraction of ab initio known MS spectra of E. coli lysate (in process).

Acknowledgement

Grant Sponsor: MIUR (Ministero dell’Istruzione, Università e Ricerca; Italian Ministry for Research and University)

Grant Contract: Funzionamento (Fondazione El.B.A Nicolini); FIRB Italnanonet (RBPR05JH2P) from MIUR to Professor Claudio Nicolini of the University of Genova.

The authors are very grateful to Prof. Marco Crescenzi for his precious cooperation and to Dr. Serena Camerini and Dr. Marialuisa Casella for performing LC-ESI MS and Vojager MALDI-TOF MS measures at the Dept of Hematology, Oncology and Molecular Medicine, Higher Institute of Health, Rome (Italy).

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • 24th World Congress on Nanomaterials and Nanotechnology
    July 12-13, 2018 Bangkok, Thailand
  • 2nd World Congress on Nano Science and Nano Technology
    August 10-11, 2018 Osaka, Japan
  • 25th Nano Congress for Future Advancements
    August 16-18, 2018 Dublin, Ireland
  • 20th Asia Pacific Nanotechnology Congress
    July 23-24, 2018 Sydney, Australia
  • 26th International Conference on Advanced Nanotechnology
    October 04-05 2018 Moscow, Russia
  • Nanotechnology & Materials Engineering
    Oct 25-26, 2018 Budapest, Hungary

Article Usage

  • Total views: 12062
  • [From(publication date):
    October-2013 - Jun 24, 2018]
  • Breakdown by view type
  • HTML page views : 8277
  • PDF downloads : 3785
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7